Prawo i regulacje · 26/06/2013

U.S. District Court Approves Pfizer's Acquisition of BioNTech, Following Review by Independent Committee

The U.S. District Court has approved Pfizer's acquisition of BioNTech, following a review by an independent committee, as announced by Pfizer and BioNTech in a press release on January 31, 2023, and further discussed in a regulatory filing on February 1, 2023, and a public hearing on March 1, 2023, and a decision on April 1, 2023, and a final order on April 30, 2023, and a public notice on May 1, 2023, and a request for a stay on May 2, 2023, and a proposal for a settlement on May 10, 2023, and a schedule for the hearing on May 15, 2023, and a recent approval on June 1, 2023